Sfoglia per RIVISTA
LEUKEMIA
Collezione ASL Asti

  

Items : 4

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. in Leukemia / Leukemia. 2020 Apr;34(4):1208-1209. doi: 10.1038/s41375-019-0616-4. Epub 2019 Nov 7.

2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

De Stefano V; Marchetti M; Vannucchi AM; Ghirardi A; Barbui T;

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. in Leukemia / Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.

2019
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli

Vannucchi AM; Alvarez-Larran A; Griesshammer M; Recasens V; Marchetti M; Tieghi A; McMullin MF; Cacciola R; Carli G; Benevolo G; Fox ML; Beggiato E; Perez-Encinas M; Lunghi F; Angona A; Wille K; Gomez M; Bertolotti L; Erez D; Palova M; Elli EM; Guglielmelli P; Casetti IC; Stephenson C; Patriarca A; Rumi E; Scaffidi L; Bonifacio M; Delaini F; et alii...

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. in Leukemia / Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.

2018
ASL Asti
ASL Vercelli

Kroeger N; Finazzi G; Bacigalupo A; Marchetti M; Koschmieder S; Hasselbalch HC; Harrison C; Mc Mullin MF; Cervantes F; Reiter A; Hehlmann R; Kiladjian JJ; Mesa R; Verstovsek S; Hoffman R; Silver RT; Passamonti F; Vannucchi AM; Tefferi A; Barbui T; Griesshammer M; Birgegard G; Barosi G;

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations. in Leukemia / Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14.

2017
ASL Asti
ASL Vercelli

Passamonti F; McMullin MF; Kröger N; Kiladjian JJ; Hehlmann R; Harrison C; Griesshammer M; Birgegård G; Cervantes F; Barosi G; Marchetti M; Vannucchi A; Barbui T;